These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3443142)

  • 1. Propranolol steady-state pharmacokinetics are unaltered by omeprazole.
    Henry D; Brent P; Whyte I; Mihaly G; Devenish-Meares S
    Eur J Clin Pharmacol; 1987; 33(4):369-73. PubMed ID: 3443142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theophylline steady state pharmacokinetics is not altered by omeprazole.
    Taburet AM; Geneve J; Bocquentin M; Simoneau G; Caulin C; Singlas E
    Eur J Clin Pharmacol; 1992; 42(3):343-5. PubMed ID: 1577056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of omeprazole on the steady-state pharmacokinetics of voriconazole.
    Wood N; Tan K; Purkins L; Layton G; Hamlin J; Kleinermans D; Nichols D
    Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):56-61. PubMed ID: 14616415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of the interaction of omeprazole and warfarin in anticoagulated patients.
    Unge P; Svedberg LE; Nordgren A; Blom H; Andersson T; Lagerström PO; Idström JP
    Br J Clin Pharmacol; 1992 Dec; 34(6):509-12. PubMed ID: 1493083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misoprostol does not alter the pharmacokinetics of propranolol.
    Bennett PN; Fenn GC; Notarianni LJ; Lee CE
    Postgrad Med J; 1991 May; 67(787):455-7. PubMed ID: 1906610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinidine single dose pharmacokinetics and pharmacodynamics are unaltered by omeprazole.
    Ching MS; Elliott SL; Stead CK; Murdoch RT; Devenish-Meares S; Morgan DJ; Smallwood RA
    Aliment Pharmacol Ther; 1991 Oct; 5(5):523-31. PubMed ID: 1793783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of propranolol pharmacokinetics and pharmacodynamics by quinidine in man.
    Yasuhara M; Yatsuzuka A; Yamada K; Okumura K; Hori R; Sakurai T; Kawai C
    J Pharmacobiodyn; 1990 Nov; 13(11):681-7. PubMed ID: 2093126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No effect of short-term omeprazole intake on acenocoumarol pharmacokinetics and pharmacodynamics.
    de Hoon JN; Thijssen HH; Beysens AJ; Van Bortel LM
    Br J Clin Pharmacol; 1997 Oct; 44(4):399-401. PubMed ID: 9354316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of oral omeprazole on the disposition of lignocaine.
    Noble DW; Bannister J; Lamont M; Andersson T; Scott DB
    Anaesthesia; 1994 Jun; 49(6):497-500. PubMed ID: 8017592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol absorption in peptic ulcer disease.
    Valdivieso A; Calvo R; Suarez E; Gonzalez JP
    Scand J Gastroenterol; 1993 Jul; 28(7):643-6. PubMed ID: 8362221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the interaction between omeprazole and cyclosporine in renal transplant patients.
    Blohmé I; Idström JP; Andersson T
    Br J Clin Pharmacol; 1993 Feb; 35(2):156-60. PubMed ID: 8443034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of omeprazole on the pharmacokinetics of saquinavir-500 mg formulation with ritonavir in healthy male and female volunteers.
    Winston A; Back D; Fletcher C; Robinson L; Unsworth J; Tolowinska I; Schutz M; Pozniak AL; Gazzard B; Boffito M
    AIDS; 2006 Jun; 20(10):1401-6. PubMed ID: 16791014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of an interaction between propranolol and sumatriptan.
    Scott AK; Walley T; Breckenridge AM; Lacey LF; Fowler PA
    Br J Clin Pharmacol; 1991 Nov; 32(5):581-4. PubMed ID: 1659437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of omeprazole on the pharmacokinetics of oral gemifloxacin in healthy volunteers.
    Allen A; Vousden M; Lewis A
    Chemotherapy; 1999; 45(6):496-503. PubMed ID: 10567781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady-state pharmacokinetics of propranolol enantiomers in healthy male volunteers.
    Paradiso-Hardy FL; Walker SE; Bowles SK
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):370-5. PubMed ID: 9707351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant decrease in nelfinavir systemic exposure after omeprazole coadministration in healthy subjects.
    Fang AF; Damle BD; LaBadie RR; Crownover PH; Hewlett D; Glue PW
    Pharmacotherapy; 2008 Jan; 28(1):42-50. PubMed ID: 18154473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonlinear accumulation of propranolol enantiomers.
    Lalonde RL; Bottorff MB; Straka RJ; Tenero DM; Pieper JA; Wainer IW
    Br J Clin Pharmacol; 1988 Jul; 26(1):100-2. PubMed ID: 3203053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of omeprazole on the pharmacokinetics of itraconazole.
    Jaruratanasirikul S; Sriwiriyajan S
    Eur J Clin Pharmacol; 1998 Apr; 54(2):159-61. PubMed ID: 9626921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omeprazole-induced increase in the absorption of bismuth from tripotassium dicitrato bismuthate.
    Treiber G; Walker S; Klotz U
    Clin Pharmacol Ther; 1994 May; 55(5):486-91. PubMed ID: 8181192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of omeprazole on the pharmacokinetics of metronidazole and hydroxymetronidazole in human plasma, saliva and gastric juice.
    Jessa MJ; Goddard AF; Barrett DA; Shaw PN; Spiller RC
    Br J Clin Pharmacol; 1997 Sep; 44(3):245-53. PubMed ID: 9296318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.